ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.17
-0.25%
Dow Jones
39,134.76
0.77%
US Dollar vs MXN
18.3332
-0.12%
Brent Oil
84.985
-0.02%
Bitcoin
64,547.63
-0.42%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Clearmind Medicine Inc (CMND)

  7. Clearmind Medicine Inc (CMND) Noticias

CMND

Clearmind Medicine (CMND)

Clearmind Medicine Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CMND
FechaHoraFuenteTítuloSímboloCompañía
20/06/202406:57GlobeNewswire Inc.Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
13/06/202415:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CMNDClearmind Medicine Inc
11/06/202406:44GlobeNewswire Inc.Clearmind Medicine Revolutionizes the $13 Billion NonAlcoholic Beverages Market with its Psychedelic-Based DrinkNASDAQ:CMNDClearmind Medicine Inc
10/05/202407:24GlobeNewswire Inc.Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage ProductNASDAQ:CMNDClearmind Medicine Inc
07/05/202406:46GlobeNewswire Inc.Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD TreatmentNASDAQ:CMNDClearmind Medicine Inc
30/04/202415:15GlobeNewswire Inc.Clearmind Applies to Cease Being a Reporting Issuer in CanadaNASDAQ:CMNDClearmind Medicine Inc
17/04/202406:49GlobeNewswire Inc.Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental DisordersNASDAQ:CMNDClearmind Medicine Inc
10/04/202406:17GlobeNewswire Inc.Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating DisordersNASDAQ:CMNDClearmind Medicine Inc
09/04/202407:07GlobeNewswire Inc.Clearmind Medicine CEO Issues Letter to ShareholdersNASDAQ:CMNDClearmind Medicine Inc
19/03/202406:55GlobeNewswire Inc.Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in ChinaNASDAQ:CMNDClearmind Medicine Inc
13/03/202407:14GlobeNewswire Inc.Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical TrialNASDAQ:CMNDClearmind Medicine Inc
13/03/202406:30GlobeNewswire Inc.Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities ExchangeNASDAQ:CMNDClearmind Medicine Inc
27/02/202406:58GlobeNewswire Inc.Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine CompoundsNASDAQ:CMNDClearmind Medicine Inc
27/02/202406:58GlobeNewswire Inc.SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine CompoundsNASDAQ:CMNDClearmind Medicine Inc
23/02/202406:06GlobeNewswire Inc.Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use DisorderNASDAQ:CMNDClearmind Medicine Inc
20/02/202406:14GlobeNewswire Inc.Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based CompoundsNASDAQ:CMNDClearmind Medicine Inc
20/02/202406:14GlobeNewswire Inc.SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based CompoundsNASDAQ:CMNDClearmind Medicine Inc
05/02/202406:51GlobeNewswire Inc.Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in ChinaNASDAQ:CMNDClearmind Medicine Inc
01/02/202407:15GlobeNewswire Inc.Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research CenterNASDAQ:CMNDClearmind Medicine Inc
16/01/202410:19GlobeNewswire Inc.Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private PlacementNASDAQ:CMNDClearmind Medicine Inc
11/01/202408:28GlobeNewswire Inc.Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private PlacementNASDAQ:CMNDClearmind Medicine Inc
10/01/202406:18GlobeNewswire Inc.Clearmind Medicine Completed Type A Meeting with the FDANASDAQ:CMNDClearmind Medicine Inc
04/01/202406:18GlobeNewswire Inc.Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based TreatmentsNASDAQ:CMNDClearmind Medicine Inc
04/01/202406:18GlobeNewswire Inc.SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based TreatmentsNASDAQ:CMNDClearmind Medicine Inc
14/12/202307:26GlobeNewswire Inc.Clearmind Medicine Announces It Is In Compliance with All Applicable Nasdaq Listing StandardsNASDAQ:CMNDClearmind Medicine Inc
05/12/202307:47GlobeNewswire Inc.Clearmind Medicine Achieved Positive Results in Cocaine Addiction TreatmentNASDAQ:CMNDClearmind Medicine Inc
01/12/202307:14GlobeNewswire Inc.Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical TrialNASDAQ:CMNDClearmind Medicine Inc
28/11/202307:25GlobeNewswire Inc.Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based TreatmentNASDAQ:CMNDClearmind Medicine Inc
27/11/202307:55GlobeNewswire Inc.Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry FiguresNASDAQ:CMNDClearmind Medicine Inc
21/11/202307:15GlobeNewswire Inc.Clearmind Medicine Announces 1-for-30 Reverse Share SplitNASDAQ:CMNDClearmind Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:CMND

Su Consulta Reciente

AMEX
EZZ
LBNK
SPONGEUSDT
SpongeBob
EU
SOLB
Solvay
UNSW
CREAMETH
Cream
BTRX
MRPHBTC
LSE
38OI
Anchor 51
BOV
COPH34
Conoco Phillips
USOTC
HHLKF
Hot Chili (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados